Hallmarks of Cancer

The hallmarks of cancer are a conceptual framework that organizes the bewildering diversity of cancers into a small set of acquired biological capabilities shared across tumor types. First articulated by Douglas Hanahan and Robert Weinberg, the framework argues that whatever the specific genotype, cancer cells converge on the same functional traits that together enable malignant growth.

Definition

The hallmarks of cancer are a set of acquired functional capabilities — such as sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis — that normal cells must acquire to become malignant, together with enabling characteristics and emerging traits added in later revisions.

Scope

The entry describes the hallmark framework and its successive expansions: the original capabilities, the later addition of enabling characteristics and emerging hallmarks, and the most recent new dimensions. It treats the hallmarks as an organizing concept for cancer biology, not as a clinical staging or grading system.

Core questions

• What functional capabilities must a normal cell acquire to become cancerous?
• How do diverse cancer genotypes converge on a shared set of behaviors?
• What enabling characteristics make acquisition of the hallmarks possible?
• How has the framework expanded since its original formulation?

Key concepts

• Sustaining proliferative signaling
• Evading growth suppressors
• Resisting cell death
• Enabling replicative immortality
• Inducing angiogenesis
• Activating invasion and metastasis
• Deregulating cellular metabolism
• Avoiding immune destruction
• Genome instability and mutation (enabling characteristic)
• Tumor-promoting inflammation (enabling characteristic)

Key theories

The hallmarks framework (2000)

The original proposal that the genotypic diversity of cancers reduces to six acquired capabilities: sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.

The next generation (2011)

An update adding two emerging hallmarks — reprogramming of energy metabolism and evading immune destruction — and two enabling characteristics — genome instability and mutation, and tumor-promoting inflammation.

New dimensions (2022)

A further extension proposing additional candidate hallmarks and enabling characteristics, including unlocking phenotypic plasticity, nonmutational epigenetic reprogramming, polymorphic microbiomes, and senescent cells.

Mechanisms

Each hallmark corresponds to the disruption of a normal homeostatic control. Sustained proliferation arises from deregulated growth-factor signaling; evasion of growth suppressors from loss of tumor suppressor function; resistance to cell death from disabled apoptotic programs; replicative immortality from telomere maintenance. Angiogenesis supplies the growing tumor with vasculature, and invasive and metastatic capabilities allow dissemination. Underlying these, enabling characteristics — genome instability that accelerates mutation, and tumor-promoting inflammation that supplies signaling support — make acquisition of the hallmarks possible. Later revisions add metabolic reprogramming, immune evasion, and phenotypic plasticity to the set.

Clinical relevance

The hallmark framework provides a shared vocabulary for relating molecular alterations to tumor behavior and for organizing the rationale behind therapies aimed at specific capabilities. It is an educational and conceptual scaffold for cancer biology and does not, by itself, prescribe diagnostic or treatment decisions for individual patients.

History

The framework was introduced in a 2000 review that distilled decades of molecular cancer research into six acquired capabilities. An influential 2011 update expanded it with emerging hallmarks and enabling characteristics, reflecting advances in metabolism and tumor immunology. A 2022 paper proposed further new dimensions, keeping the framework current with developments in epigenetics, plasticity, and the microbiome.

Debates

Are the hallmarks a complete or definitive list?

The framework has been revised repeatedly, with new candidate hallmarks and enabling characteristics proposed over time; whether the set is fixed or an evolving heuristic is part of how the concept is used.

Key figures

• Douglas Hanahan
• Robert Weinberg

Seminal works

• hanahan-weinberg-2000
• hanahan-weinberg-2011
• hanahan-2022

Frequently asked questions

How many hallmarks of cancer are there?

The original 2000 framework described six; the 2011 update added two emerging hallmarks and two enabling characteristics, and the 2022 paper proposed further new dimensions, so the number depends on the version referenced.

What is the difference between a hallmark and an enabling characteristic?

A hallmark is an acquired functional capability of cancer cells, while an enabling characteristic — such as genome instability or tumor-promoting inflammation — is a property that facilitates acquisition of those capabilities.